Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
PZ HTL SA
GLOBETECH PUBLISHING LLC

European Bioinformatics Sector Expected to Surge

By BiotechDaily International staff writers
Posted on 01 Jun 2014
An intra-European purchase agreement will boost the bioinformatics field by combining an exhaustive genomics data base with a highly intuitive software suite.

Qiagen N.V. (Venlo, The Netherlands) will be expanding its industry-leading portfolio of bioinformatics solutions called "Ingenuity Knowledge Base" by incorporating the genomics analysis and sequencing data that comprises the Biobase (Wolfenbüttel, Germany) HGMD (Human Gene Mutation Database) and PGMD (PharmacoGenomic Mutation Database) databases.

HGMD provides comprehensive data on human inherited disease mutations. Widely used in human genetics research, diagnostics, and personal genomics, HGMD enables quick access to single mutation queries and advanced search applications. PGMD identifies all published gene variants that have been shown to affect drug response in patients, with multiple delivery models for accessing this data, including an intuitive exploratory interface and a data download for in-house analysis systems.

“The ability of next-generation sequencing (NGS) to rapidly deliver genomic insights is opening up new frontiers for clinical research and medicine, and Qiagen is strategically addressing customers’ needs to interpret the massive amounts of data generated by NGS. With HGMD and other content from Biobase, a respected organization with a dedicated team and robust line of unique databases and software, Qiagen is further extending its competitive advantage as the overall market leader for clinical interpretation of human sequencing data,” said Peer M. Schatz, CEO of Qiagen. “Already today, more than 15,000 users worldwide rely on Qiagen’s bioinformatics products for interpretation and have processed over a quarter of a million genome sequences. HGMD is a unique fit with our offering and will integrate well. We expect to drive additional adoption of this leading literature-based knowledge base used by clinical reference labs for annotating hereditary variants, as well as Biobase’ other solutions by having integrated them into interpretation solutions shared with our Ingenuity Knowledge Base, adding value for Qiagen and Biobase customers and accelerating our growth drivers in NGS and bioinformatics.”

When the acquisition has been completed, Biobase will be renamed Qiagen Wolfenbüttel.

Related Links:
Qiagen N.V.
Biobase



comments powered by Disqus

Channels

Genomics/Proteomics

view channel

New Program Encourages Wide Distribution of Genomic Data

A new data sharing program allows genomics researchers and practitioners to analyze, visualize, and share raw sequence data for individual patients or across populations straight from a local browser. The sequencing revolution is providing the raw data required to identify the genetic variants underlying rare diseases... Read more

Drug Discovery

view channel
Image: The nano-cocoon drug delivery system is biocompatible, specifically targets cancer cells, can carry a large drug load, and releases the drugs very quickly once inside the cancer cell. Ligands on the surface of the \"cocoon\" trick cancer cells into consuming it. Enzymes (the “worms\" in this image) inside the cocoon are unleashed once inside the cell, destroying the cocoon and releasing anticancer drugs into the cell (Photo courtesy of Dr. Zhen Gu, North Carolina State University).

Novel Anticancer Drug Delivery System Utilizes DNA-Based Nanocapsules

A novel DNA-based drug delivery system minimizes damage to normal tissues by utilizing the acidic microenvironment inside cancer cells to trigger the directed release of the anticancer drug doxorubicin (DOX).... Read more

Lab Technologies

view channel

Experimental Physicists Find Clues into How Radiotherapy Kills Cancer Cells

A new discovery in experimental physics has implications for a better determination of the process in which radiotherapy destroys cancer cells. Dr. Jason Greenwood from Queen’s University Belfast (Ireland) Center for Plasma Physics collaborated with scientists from Italy and Spain on the work on electrons, and published... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.